| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.
|
J Clin Oncol
|
2001
|
11.35
|
|
2
|
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.
|
N Engl J Med
|
2003
|
11.35
|
|
3
|
Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.
|
J Clin Oncol
|
2005
|
6.38
|
|
4
|
International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.
|
J Clin Oncol
|
2011
|
5.95
|
|
5
|
Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer.
|
Eur Urol
|
2014
|
1.81
|
|
6
|
Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder.
|
Cancer
|
2006
|
1.75
|
|
7
|
A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy.
|
Lancet Oncol
|
2011
|
1.33
|
|
8
|
Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer.
|
Cancer
|
2015
|
0.97
|
|
9
|
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.
|
Oncologist
|
2016
|
0.83
|
|
10
|
A new staging criterion for bladder carcinoma using gadolinium-enhanced magnetic resonance imaging with an endorectal surface coil: a comparison with ultrasonography.
|
BJU Int
|
2000
|
0.78
|
|
11
|
Urothelial carcinoma management in elderly or unfit patients.
|
EJC Suppl
|
2016
|
0.78
|
|
12
|
Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder.
|
Urol Oncol
|
2003
|
0.78
|